 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| Concentration | Treated Time | Description | References | |
| human microvascular endothelial cells (HMVEC) | 100 µM | 18 hours | MA inhibits Piezo1 currents by increasing the mechanical threshold required for activation. | Nat Commun. 2019 Mar 13;10(1):1200 | 
| mouse neuro-2a (N2A) cells | 100 µM | 18 hours | MA inhibits Piezo1 currents by increasing the mechanical threshold required for activation. | Nat Commun. 2019 Mar 13;10(1):1200 | 
| colonic circular muscle cells | 50 and 100 μM | to investigate the effects of C17:0 and C18:0 on colonic muscle contraction, showing they dose-dependently enhanced contraction amplitudes | Microbiome. 2018 Jun 14;6(1):107 | |
| primary mouse hepatocytes | 125 µM | 24 or 48 hours | To evaluate the effects of heptadecanoic acid on lipid metabolism and inflammatory signaling in hepatocytes. Results showed that C17:0 treatment increased the expression of lipogenic genes but had no effect on insulin-stimulated AKT phosphorylation, while suppressing JAK2/STAT3 signaling. | Nutrients. 2023 Apr 24;15(9):2052 | 
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6JRj mice | High-fat diet-induced hepatic steatosis and insulin resistance model | Dietary supplementation | 5% | For 20 weeks | To assess the effects of long-term heptadecanoic acid supplementation on high-fat diet-induced hepatic steatosis and insulin resistance. Results showed that C17:0 supplementation did not improve hepatic lipid accumulation or insulin resistance and had no significant effect on hepatic lipid metabolism. | Nutrients. 2023 Apr 24;15(9):2052 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 3.70mL 0.74mL 0.37mL | 18.49mL 3.70mL 1.85mL | 36.98mL 7.40mL 3.70mL | |
| CAS号 | 506-12-7 | 
| 分子式 | C17H34O2 | 
| 分子量 | 270.45 | 
| SMILES Code | CCCCCCCCCCCCCCCCC(O)=O | 
| MDL No. | MFCD00002751 | 
| 别名 | 十七碳酸 ;C17:0 Fatty acid; C17:0; Margarinic acid; n-Heptadecanoic acid; 506-12-7; Margaric acid | 
| 运输 | 蓝冰 | 
| InChI Key | KEMQGTRYUADPNZ-UHFFFAOYSA-N | 
| Pubchem ID | 10465 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C | 
| 溶解方案 | DMSO: 105 mg/mL(388.24 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1